97
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Assessment of vascular function in complete glycaemic spectrum

, , , , &
Pages 436-442 | Received 04 Feb 2021, Accepted 14 Feb 2021, Published online: 11 Mar 2021

References

  • Scholte AJSJ, Kharagjitsingh AV, Jukema JW, Van Der Wall EE, Van Der Wall EE, Bax JJ.Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008;94(3):290–95. doi:10.1136/hrt.2007.121921.
  • Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM.Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99(18):2434–39. doi:10.1161/01.CIR.99.18.2434.
  • Schachinger V, Britten MB, Zeiher AM.Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101(16):1899–906. doi:10.1161/01.CIR.101.16.1899.
  • Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A.Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37(5):1236–41. doi:10.1161/01.HYP.37.5.1236.
  • Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S.Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39(1):10–15. doi:10.1161/hy0102.099031.
  • Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG.Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106(16):2085–90. doi:10.1161/01.CIR.0000033824.02722.F7.
  • Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA.Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 1999;105(10):110–16. doi:10.1016/S0735-1097(03)00333-4.
  • Hatsuda S, Shoji T, Shinohara K, Kimoto E, Mori K, Fukumoto S, Koyama H, Emoto M, Nishizawa Y. Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus. J Atheroscler Thromb. 2006;13:114–21.
  • Kullo IJ, Malik AR, Bielak LF, Sheedy PF, Turner ST, Peyser PA.Brachial artery diameter and vasodilator response to nitroglycerine, but not flow-mediated dilatation, are associated with the presence and quantity of coronary artery calcium in asymptomatic adults. Clin Sci. 2001;104(3):2673–78. doi:10.1042/CS20060131.
  • Giacco F, Brownlee M.Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–70. doi:10.1161/CIRCRESAHA.110.223545.
  • Uusitupa M, Niskanen L, Sutonen O, Pyo¨ra¨la¨ K. Hyperinsulinemia and hypertension in patients with newly diagnosed non-insulin dependent diabetes. Diabetes Metab. 1987;13:369–74.
  • Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48(9):1856–62. doi:10.2337/diabetes.48.9.1856.
  • Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000;101(15):1780‐1784. doi:10.1161/01.CIR.101.15.1780.
  • Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–65. doi:10.1016/S0735-1097(01)01746-6.
  • Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet (London, England). 1992;340(8828):1111-5.
  • Celermajer DS.Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol. 2002;39(2):257–65. doi:10.1016/S0735-1097(97)00189-7.
  • Felmeden D, Spencer C, Belgore F, Blann A, Beevers D, Lip G.Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens. 1992;340(1):11–20. doi:10.1016/S0895-7061(02)03149-7.
  • Mannucci PM.von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol. 1998;18(9):1359‐1362. doi:10.1161/01.ATV.18.9.1359.
  • Lip GY, Blann A.von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1992;340(8828):255‐265. doi:10.1016/S0008-6363(97)00039-4.
  • Cerrato R, Cunnington C, Crabtree MJ, et al. Endothelin-1 increases superoxide production in human coronary artery bypass grafts. Life Sci. 2012;91(13-14):723-8.
  • Pernow J, Shemyakin A, Böhm F.New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sci. 2012;91(13–14):507‐516. doi:10.1016/j.lfs.2012.03.029.
  • Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes care. 2003;26(11):3160-7.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(Suppl. 1):S62–S69. doi:10.2337/dc11-S062.
  • The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183–97. doi:10.2337/diacare.20.7.1183.
  • Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. doi:10.1001/jama.289.19.2560.
  • Uehata A, Lieberman EH, Gerhard MD, et al. Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery. Vascular medicine (London, England). 1997;2(2):87–92. doi:10.1177/1358863X9700200203.
  • Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluatingbrachial artery vasodilatation using high-frequency ultrasound. Am JPhysiol. 1995;268:H1397–H1404.
  • Li H, Isomaa B, Taskinen MR, Groop L, Tuomi T.Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care. 2000;23(5):589–94. doi:10.2337/diacare.23.5.589.
  • Behrendt D, Ganz P.Endothelial function. From vascular biology to clinical applications. Am J Cardiol. 2002;90(10):40l–8l. doi:10.1016/S0002-9149(02)02963-6.
  • Bonetti PO, Lerman LO, Lerman A.Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168–75. doi:10.1161/01.ATV.0000051384.43104.FC.
  • Neunteufl T, Katzenschlager R, Hassan A, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 1997;129(1):111–18. doi:10.1016/S0021-9150(96)06018-2.
  • Teragawa H, Ueda K, Matsuda K, Kimura M, Higashi Y, Oshima T, et al. Relationship between endothelial function in the coronary and brachial arteries. Clin Cardiol. 2005;28(10):460–66. doi:10.1002/clc.4960281004.
  • Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26(5):1235–41. doi:10.1016/0735-1097(95)00327-4.
  • Takase B, Hamabe A, Satomura K, et al. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease. Circ J. 2006;70(1):49–56. doi:10.1253/circj.70.49.
  • Fadini GP, Sartore S, Agostini C, Avogaro A.Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care. 2007;30(5):1305–13. doi:10.2337/dc06-2305.
  • Chou E, Suzuma I, Way KJ, et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation. 2002;105(3):373–79. doi:10.1161/hc0302.102143.
  • Schiffrin EL.Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens. 2001;14(11):83s–9s. doi:10.1016/S0895-7061(01)02074-X.
  • Kalani M.The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag. 2008;4(5):1061–68. doi:10.2147/VHRM.S3920.
  • Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. The Journal of clinical investigation. 1993;92(1):398–403. doi:10.1172/JCI116579.
  • Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. The Journal of experimental medicine. 1990;172(6):1741–48. doi:10.1084/jem.172.6.1741.
  • Sessa WC, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun. 1991;174:613–18.
  • Barton M, Haudenschild CC, d’Uscio LV, Shaw S, Munter K, Luscher TF.Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2001;37(24):14367–72. doi:10.1073/pnas.95.24.14367.
  • Lerman A, Webster MW, Chesebro JH, Edwards WD, Wei CM, Fuster V, et al. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 1993;88(6):2923–28. doi:10.1161/01.CIR.88.6.2923.
  • Guvener N, Aytemir K, Aksoyek S, Gedik O.Plasma endothelin-1 levels in non-insulin dependent diabetes mellitus patients with macrovascular disease. Coron Artery Dis. 1998;95(5):14367–72. doi:10.1097/00019501-199705000-00001.
  • Smulders RA, Stehouwer CD, Olthof CG, Van Kamp GJ, Teerlink T, De Vries PM, Donker AJ.Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci. 1993;88(1):37–43. doi:10.1042/cs0870037.
  • Takahashi K, Ghatei MA, Lam HC, O’Halloran DJ, Bloom SR.Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 1990;33(5):306–10. doi:10.1007/BF00403325.
  • McAllister AS, Atkinson AB, Johnston GD, McCance DR.Endothelial function in offspring of Type 1 diabetic patients with and without diabetic nephropathy. Diabetic Med. 1999;16(4):298–303. doi:10.1046/j.1464-5491.1999.00050.x.
  • Zizek B, Poredos P, Videcnik V.Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension. Heart. 2001;85(2):215–17. doi:10.1136/heart.85.2.215.
  • Schneider JG, Tilly N, Hierl T, Sommer U, Hamann A, Dugi K, et al. Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens. 2002;15(11):967–72. doi:10.1016/S0895-7061(02)03060-1.
  • Sadler JE. von Willebrand factor. J Biol Chem. 1991;266(34):22777–80. doi:10.1016/S0021-9258(18)54418-5.
  • Lowe GD, Rumley A, Whincup PH, Danesh J.Hemostatic and rheological variables and risk of cardiovascular disease. Semin Vasc Med. 2002;2(4):429–39. doi:10.1055/s-2002-36771.
  • Jager A, Van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler ThrombVasc Biol. 1999;19(12):3071–78. doi:10.1161/01.ATV.19.12.3071.
  • Lip GY, Pearce LA, Chin BS, Conway DS, Hart RG.Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation. Heart. 2005;91(6):759–63. doi:10.1136/hrt.2004.036160.
  • Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG.Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med. 2000;133(2):81–91. doi:10.7326/0003-4819-133-2-200007180-00007.
  • Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GD.von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002;23(22):1764–70. doi:10.1053/euhj.2001.3237.
  • Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, Amouyel P, Evans A, Ducimetiere P, Juhan-Vague I.Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation. 2004;109(11):1343–48. doi:10.1161/01.CIR.0000120705.55512.EC.
  • Bongers TN, De Maat MP, Van Goor ML, Bhagwanbali V, Van Vliet HH, Gomez Garcia EB, Dippel DW, Leebeek FW.High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke. 2006;37(11):2672–77. doi:10.1161/01.STR.0000244767.39962.f7.
  • Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG.Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation. 2007;115(16):2119–27. doi:10.1161/CIRCULATIONAHA.106.635029.
  • Chion CK, Doggen CJ, Crawley JT, Lane DA, Rosendaal FR.ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood. 2007;109(5):1998–2000. doi:10.1182/blood-2006-07-038166.
  • Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ.Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994;88(3):601–07. doi:10.1111/j.1365-2141.1994.tb05079.x.
  • Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP, Factor VIII.von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol. 1999;105(1):110–16. doi:10.1111/j.1365-2141.1999.01317.x.
  • Tzoulaki I, Murray GD, Price JF, Smith FB, Lee AJ, Rumley A, Lowe GD, Fowkes FG.Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol. 2007;115(4):2119–27. doi:10.1093/aje/kwj051.
  • Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G.Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation. 2005;112(20):3080–87. doi:10.1161/CIRCULATIONAHA.105.557132.
  • Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction,xidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2673–78. doi:10.1161/hc4601.099485.
  • Kinlay S, Creager MA, Fukumoto M, et al. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension. 2001;38(5):1049–53. doi:10.1161/hy1101.095329.
  • Nigam A, Mitchell GF, Lambert J, Tardif JC.Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol. 2003;92(4):395–99. doi:10.1016/S0002-9149(03)00656-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.